Almirall Jordi, Bolíbar Ignasi, Toran Pere, Pera Guillem, Boquet Xavier, Balanzó Xavier, Sauca Goretti
Intensive Care Unit, Hospital de Mataró, Mataró, Barcelona, Spain.
Chest. 2004 Apr;125(4):1335-42. doi: 10.1378/chest.125.4.1335.
To assess the usefulness of serum C-reactive protein (CRP) in the diagnosis and treatment approach of patients with community-acquired pneumonia (CAP).
Population-based case-control study.
A mixed residential-industrial urban area of 74,368 adult inhabitants in the Maresme region (Barcelona, Spain).
From December 1993 to November 1995, all subjects who were > 14 years of age, were living in the area, and had received a diagnosis of CAP, which had been confirmed by chest radiographs and compatible clinical outcome, were registered. Patients from residential care facilities were excluded. Serum samples were assayed for CRP in the acute phase of the disease. Data from 201 patients with CAP were compared with 84 healthy control subjects matched by age, sex, and municipality, as well as with 25 patients with initially suspected pneumonia that was not confirmed at follow-up. Median CRP levels were 110.7, 1.9, and 31.9 mg/L, respectively. The thresholds of the test for discriminating among these three groups of subjects were 11.0 and 33.15 mg/L.
Eighty-nine patients (44.8%) had an identifiable etiology. The most common pathogens were Streptococcus pneumoniae, viruses, and Chlamydia pneumoniae, followed by Mycoplasma pneumoniae, Legionella pneumophila, and Coxiella burnetii. There were statistically significant differences in the median CRP levels in pneumococcal (166.0 mg/L) and L pneumophila (178.0 mg/L) etiologies compared to other causative pathogens. Lower levels of CRP were found in pneumonia caused by viruses and C burnetii as well as in negative microbiological findings. The median CRP levels in hospitalized patients were significantly higher than in outpatients (132.0 vs 76.9 mg/L, respectively; p < 0.001). Considering a cut point of 106 mg/L in men and 110 mg/L in women for deciding about the appropriateness of inpatient care, CRP levels showed a sensitivity of 80.51% and a specificity of 80.72%.
Serum CRP level is a useful marker for establishing the diagnosis of CAP in adult patients with lower respiratory tract infections. High CRP values are especially high in patients with pneumonias caused by S pneumoniae or L pneumophila. Moreover, high CRP values are suggestive of severity, which may be of value in deciding about the appropriateness of inpatient care.
评估血清C反应蛋白(CRP)在社区获得性肺炎(CAP)患者诊断和治疗方法中的作用。
基于人群的病例对照研究。
西班牙巴塞罗那马雷斯梅地区一个有74368名成年居民的商住混合市区。
1993年12月至1995年11月,登记了所有年龄大于14岁、居住在该地区且经胸部X光片及相符的临床结果确诊为CAP的患者。排除来自寄宿护理机构的患者。在疾病急性期检测血清样本中的CRP。将201例CAP患者的数据与84名年龄、性别和所在城市相匹配的健康对照者,以及25例最初疑似肺炎但随访时未确诊的患者的数据进行比较。三组对象的CRP中位数水平分别为110.7、1.9和31.9mg/L。区分这三组对象的检测阈值为11.0和33.15mg/L。
89例患者(44.8%)有可识别的病因。最常见的病原体是肺炎链球菌、病毒和肺炎衣原体,其次是肺炎支原体、嗜肺军团菌和伯氏考克斯体。与其他致病病原体相比,肺炎链球菌(166.0mg/L)和嗜肺军团菌(178.0mg/L)病因的CRP中位数水平有统计学显著差异。病毒和伯氏考克斯体引起的肺炎以及微生物学检查结果为阴性时,CRP水平较低。住院患者的CRP中位数水平显著高于门诊患者(分别为132.0和76.9mg/L;p<0.001)。以男性106mg/L、女性110mg/L作为判断住院治疗是否合适的切点,CRP水平的敏感性为80.51%,特异性为80.72%。
血清CRP水平是诊断成年下呼吸道感染患者CAP的有用标志物。肺炎链球菌或嗜肺军团菌引起的肺炎患者的CRP值尤其高。此外,高CRP值提示病情严重,这可能对决定住院治疗是否合适有价值。